Scot C. Remick

Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data

Nathan Levitan, Afshin Dowlati, Scot C. Remick et al. · Medicine · 1999 · 892 citations

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

Afshin Dowlati, Kelly M. Robertson, Matthew M. Cooney et al. · PubMed · 2002 · 406 citations

Pharmacotherapy, Metronomic Chemotherapy, Tumor Biology +17

Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors

Michael L. Maitland, George L. Bakris, Henry R. Black et al. · JNCI Journal of the National Cancer Institute · 2010 · 404 citations · Full text

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +23

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan et al. · Blood · 2009 · 255 citations · Full text

Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid

P. Savvides, Govardhanan Nagaiah, Pierre Lavertu et al. · Thyroid · 2012 · 213 citations · Full text